Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Clin Cancer Res. 2015 Aug 6;22(1):61–68. doi: 10.1158/1078-0432.CCR-15-0979

Figure 4.

Figure 4

Scatter plot showing correlation between CA19-9 changes (x-axis) and relative changes in frequency of the most frequent mutant allele in cfDNA as determined by the Guradant360 assay (y-axis). Spearman's Rho was calculated to assess for correlation.